Tulobuterol transdermal (NAL Pharma)

N/A

Report date: 2025/03/25 09:40:09

Base Information

Drug NameTulobuterol transdermal (NAL Pharma)
Drug Alias NameNAL6328NAL-6328
ClassificationSmall molecules
Mechanisms of ActionBeta-2 adrenergic receptor agonists
TargetsBeta-2 adrenergic receptor
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesNal Pharma LTD
China Registration ClassN/A

Develop Information

Active CompaniesNal Pharma LTD
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A